CRBN and plasma cell myeloma: The result showed that those with lower CASP-8 mRNA levels exhibited a higher overall survival rate (Figure 6B), suggesting that CASP-8 expression may be an important factor in determining the clinical response to Len-based therapies likely through the regulation of CRBN protein level in myeloma.